CAMBRIAN BIOPHARMA INC sold 16.1% of their position (25K shares) of SENSEI BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $500.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/1/2026ACC: 0000897069-26-001299
10% Owner
Since Feb 2021
-25K
Net shares
Net seller
$500.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−24.52K
Price / share
$20.00
Trade value
$490.48K
% of position
15.8%
6/1/2026
155.14K→130.62K
Common Stock
Direct
Shares
−476.00
Price / share
$21.14
Trade value
$10.06K
% of position
0.4%
6/1/2026
130.62K→130.14K
Total
Net shares
−25K
Net value
-$500.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −24.52K | $20.00 | $490.48K | 15.8% | 155.14K | 130.62K |
| Common Stock Direct | 6/1/2026 | S · Sale | −476.00 | $21.14 | $10.06K | 0.4% | 130.62K | 130.14K |
| Total | −25K | -$500.54K | ||||||
Derivative Transactions0
No derivative transactions reported